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Distinct adipocyte progenitor cells may reveal therapeutic strategies for obesity 7 
 8 
Fat tissue is essential for the safe storage of excess calories and thereby plays a key role in metabolic health. 9 
By storing lipid droplets, fat cells (adipocytes) protect organs from the damaging effects of ectopic lipid 10 
accumulation (1). Understanding how to promote healthy fat expansion may therefore reveal treatments for 11 
obesity and related diseases. Such expansion depends on the formation of new adipocytes from progenitor 12 
cells within fat tissue (2). Distinct populations of adipocyte progenitor cells (APCs) have been identified, but 13 
their interrelationships and relevance to physiological and pathological fat expansion have remained poorly 14 
understood (3). On page 353 of this issue, Merrick et al. (4) identify three new classes of APCs that are 15 
regulated with obesity, one of which resides in a potential new stem cell niche for tissue regeneration and 16 
repair. 17 
Deciphering APC biology is complicated by the heterogeneous nature of fat tissue. To isolate APCs from 18 
the fat of mice, Merrick et al. used a method called fluorescence-activated cell sorting (FACS), which 19 
separates fat cells based on the presence of specific cell-surface proteins. This cellular pool was further 20 
resolved using single-cell RNA sequencing (scRNAseq), allowing cells to be grouped on the basis of 21 
similarities in their gene expression. Most cells fell into one of three groups that had not been defined 22 
previously: interstitial progenitor cells (IPCs), defined by expression of a protein called dipeptidyl peptidase–4 23 
(DPP4); preadipocytes, marked by expression of intercellular adhesion molecule–1 (ICAM1); and group 3 24 
cells, which expressed the protein CD142 (see the figure). Each group formed adipocytes in cell culture, thus 25 
supporting their identification as APCs.  26 
Different types of fat tissue, called depots, exist in distinct anatomical locations, with distinct cellular and 27 
functional characteristics and pathological implications (2). Do APC classes differ between depots? Merrick 28 
et al. found that visceral fat has fewer IPCs than subcutaneous fat, analogous to depot-dependent differences 29 
reported elsewhere (5-9). It remains unclear whether these APCs exist in other depots, such as bone marrow 30 
fat (10); however, they were also detected in brown fat, a depot that may help treat obesity. 31 
To determine whether different APC classes interconvert in vivo, Merrick et al. obtained IPCs, 32 
preadipocytes, and group 3 cells from newborn mice genetically engineered to express a red fluorescent 33 
protein. This allowed the cells to be tracked after transplantation into normal newborn recipients. Doing so 34 
revealed that IPCs acted as progenitors for both ICAM1+ and CD142+ cells, which themselves interconverted 35 
in vivo but did not revert to IPCs. Each of these APC types also gave rise to adipocytes in vivo, further 36 
demonstrating their role in fat development. The use of newborn mice is notable: Other studies focused on 37 
adults only (5, 7, 9, 10), leaving the developmental relevance of the APCs studied unclear. By contrast, Merrick 38 
et al. identified IPCs, preadipocytes, and group 3 cells in adults and newborns, observing similar proportions 39 
at each age. This suggests that these APCs contribute not only to postnatal fat development but perhaps also 40 
to maintenance of fat tissue in adults. Analysis of adult APCs by scRNAseq and in vivo tracking could address 41 
this possibility.  42 
What about the pathological relevance of the APC subtypes? Merrick et al. noted that in obese, glucose-43 
intolerant mice, visceral fat had fewer IPCs and a greater proportion of group 3 cells, similar to what was found 44 
in previous reports about other APCs (9). However, they also found that in obesity, the ability of preadipocytes 45 
or group 3 cells to form adipocytes is enhanced in subcutaneous fat but impaired in visceral fat. Such 46 
differences might contribute to the different health implications of excessive visceral versus subcutaneous fat 47 
storage.  48 
Merrick et al. used the same approach to study APCs in subcutaneous fat of humans. The authors identified 49 
two general classes of APCs, analogous to the IPCs and preadipocytes in mice; however, group 3 APCs were 50 
not detected. By contrast, another study defined CD142+ APCs as adipogenesis regulatory cells that exist in 51 
the fat of mice and humans, suppressing adipocyte formation in each species (9). Unlike Merrick et al., this 52 
study analyzed human fat by FACS only. Thus, it seems likely that technical differences might underlie these 53 
inconsistencies.  54 
 2 
A major challenge is that different studies classify APC subtypes based on distinct criteria, making it difficult 55 
to reach a consensus. The study of Merrick et al. directly compared the characteristics of the APCs they 56 
identified with those of other studies, demonstrating how their IPCs, preadipocytes, and group 3 cells overlap 57 
with other APC subtypes identified elsewhere (5, 7, 9). However, there is likely to be further heterogeneity 58 
among these APC classes, and other distinct subtypes may also exist. It would be helpful for the field to reach 59 
some consensus around the identities of such APC classes, the methods used to characterize them, and their 60 
existence in humans.  61 
Many reports indicate that APCs reside near blood vessels (2, 3), but Merrick et al. noted that IPCs were 62 
found within the reticular interstitium, a fluid-filled network of collagen and elastin fibers that encases many 63 
organs. By contrast, preadipocytes were observed beyond the reticular interstitium, adjacent to adipocytes. 64 
Between the IPCs and preadipocytes were cells expressing both DPP4 and ICAM1, suggesting a transition 65 
from IPCs to preadipocytes. The presence of IPCs within the reticular interstitium was assessed only for 66 
subcutaneous fat of mice. Hence, it remains unclear if this represents a common site for IPCs among all fat 67 
depots, or if it is analogous to the mesothelium as a source for visceral fat progenitors (6). Whether the reticular 68 
interstitium plays a role in humans also remains to be determined. However, given that the reticular interstitium 69 
exists in multiple human tissues (11),, an intriguing possibility is that it represents a new stem cell niche for fat 70 
tissue and beyond.  71 
Adipose formation and function are influenced by diverse physiological and pathological factors, including 72 
genetics, age, sex, ethnicity, diet, and many clinical conditions. What is the relationship between these factors, 73 
APC function, and the reticular interstitium? Moreover, some antidiabetic drugs can modulate APC dynamics 74 
(12), and DPP4 is a target of other antidiabetic therapies (10). Whether such treatments can influence the 75 
DPP4-expressing IPCs, or other APC subtypes, remains unknown.  76 
A major challenge will be to determine the implications of altered APC function in health and disease. Doing 77 
so holds great promise: By further unraveling the mysteries of APC biology, we may ultimately be able to 78 
target these cells to improve human health.  79 
  80 
REFERENCES  81 
1. S. Carobbio, et al., Adv Exp Med Biol 960, 161 (2017). 82 
2. R. Berry, et al., Cell metabolism 19, 8 (2014). 83 
3. W. P. Cawthorn, et al., J Lipid Res 53, 227 (2012). 84 
4. D. Merrick, et al., Science X, XXX (2019). 85 
5. R. B. Burl, et al., Cell Metab 28, 300 (2018). 86 
6. Y. Y. Chau, et al., Nature Cell Biology 16, 367 (2014). 87 
7. C. Hepler, et al., Elife 7, 10.7554/eLife.39636 (2018). 88 
8. K. Y. Lee, et al., EMBO J 38, 10.15252/embj.201899291 (2019). 89 
9. P. C. Schwalie, et al., Nature 559, 103 (2018). 90 
10. T. H. Ambrosi, et al., Cell Stem Cell 20, 771 (2017). 91 
11. P. C. Benias, et al., Scientific Reports 8, 4947 (2018). 92 
12. W. Tang, et al., Cell Metab 14, 116 (2011). 93 
 94 
Acknowledgments  95 
The authors are supported by grants from the Medical Research Council (MR/M021394/1 to W.P.C.) and 96 

































Figure 1 – Fat cell progenitors  129 
Interstitial progenitor cells (IPCs), preadipocytes, and group 3 cells are adipocyte progenitor cells (APCs) 130 
that are present in different fat depots of mice. These cell types interconvert and are altered in obesity, 131 
highlighting potential physiological and pathological implications. IPCs in subcutaneous fat reside in the 132 
reticular interstitium, which might represent a new stem cell niche for fat cells. 133 
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Fat cell progenitors
Interstitial progenitor cells (IPCs), preadipocytes, and group 3 cells are adipocyte 
progenitor cells (APCs) that are present in different fat depots of mice.  These cell 
types interconvert and are altered in obesity, highlighting potential physiological 
and pathological implications.  IPCs in subcutaneous fat reside in the reticular 
interstitium, which might represent a new stem cell niche for fat cells.
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